These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Indications for mianserin in relation to its absence of side-effects (author's transl)]. Calanca MA Acta Psychiatr Belg; 1978; 78(5):781-6. PubMed ID: 375682 [TBL] [Abstract][Full Text] [Related]
9. Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation. Thase ME; Kupfer DJ; Frank E; Jarrett DB J Clin Psychiatry; 1989 Nov; 50(11):413-7. PubMed ID: 2509437 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. Flint AJ; Rifat SL J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693 [TBL] [Abstract][Full Text] [Related]
11. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation. Licht RW; Qvitzau S Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of the treatment with tetracyclic and tricyclic antidepressants in patients with minor depressive disorders. Tudor S; Zaharia M Rom J Neurol Psychiatry; 1994; 32(3):185-98. PubMed ID: 7710969 [TBL] [Abstract][Full Text] [Related]